HQ: Cambridge, MA, USACEO: John LeonardHeadcount: 600+intelliatx.com ↗
Funding Summary
Total Funding
$1B+
Latest Valuation
~$3B (public market cap)
About
Leading in vivo CRISPR gene editing company with the first clinical data showing CRISPR can edit genes directly inside the human body (NTLA-2001 for ATTR). Co-founded by Jennifer Doudna.
Products
in-vivo-crispr-editing
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →